DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Pridinol

Pridinol

  • Microneedle Device and Transdermal Administration Device Provided with Microneedles

    Microneedle Device and Transdermal Administration Device Provided with Microneedles

  • The In¯Uence of Medication on Erectile Function

    The In¯Uence of Medication on Erectile Function

  • Affinity Profiles of Hexahydro-Sila-Difenidol Analogues at Muscarinic Receptor Subtypes

    Affinity Profiles of Hexahydro-Sila-Difenidol Analogues at Muscarinic Receptor Subtypes

  • Pharmacokinetics of Oral Pridinol: Results of a Randomized, Crossover Bioequivalence Trial in Healthy Subjects

    Pharmacokinetics of Oral Pridinol: Results of a Randomized, Crossover Bioequivalence Trial in Healthy Subjects

  • Prohibited Substances List

    Prohibited Substances List

  • Solubilization of the Muscarinic Acetylcholine Receptor by I Sodium Cholate: Stabilization of the Receptor by Muscarinic Hgands

    Solubilization of the Muscarinic Acetylcholine Receptor by I Sodium Cholate: Stabilization of the Receptor by Muscarinic Hgands

  • Predicting Therapeutic and Aggravating Drugs for Hepatocellular Carcinoma Based on Tissue- Specific Pathways

    Predicting Therapeutic and Aggravating Drugs for Hepatocellular Carcinoma Based on Tissue- Specific Pathways

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • DIFEN FLEX Eliminated During the First 12 Hours Following Administration

    DIFEN FLEX Eliminated During the First 12 Hours Following Administration

  • Full-Text (PDF)

    Full-Text (PDF)

  • 2021 Equine Prohibited Substances List

    2021 Equine Prohibited Substances List

  • United States Patent (19) 11 Patent Number: 6,071,970 Mueller Et Al

    United States Patent (19) 11 Patent Number: 6,071,970 Mueller Et Al

  • Identification of New Functional Inhibitors of Acid Sphingomyelinase

    Identification of New Functional Inhibitors of Acid Sphingomyelinase

  • Drug Compounding Ingredients Comprising N-Substituted-O-Toluidine Derivative and Percutaneously Absorbable Preparation

    Drug Compounding Ingredients Comprising N-Substituted-O-Toluidine Derivative and Percutaneously Absorbable Preparation

  • Association Between Antipsychotic Agents and Risk of Acute Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease

    Association Between Antipsychotic Agents and Risk of Acute Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease

  • Thermodynamics of Antagonist Binding to Rat Muscarinic M2 Receptors: Antimuscarinics of the Pridinol, Sila-Pridinol, Diphenidol and Sila-Diphenidol Type

    Thermodynamics of Antagonist Binding to Rat Muscarinic M2 Receptors: Antimuscarinics of the Pridinol, Sila-Pridinol, Diphenidol and Sila-Diphenidol Type

  • Marrakesh Agreement Establishing the World Trade Organization

    Marrakesh Agreement Establishing the World Trade Organization

  • Stereoselective Inhibition of Muscarinic Receptor Subtypes by the Enantiomers of Hexahydro-Difenidol and Acetylenic Analogues

    Stereoselective Inhibition of Muscarinic Receptor Subtypes by the Enantiomers of Hexahydro-Difenidol and Acetylenic Analogues

Top View
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • 2019 Equine Prohibited Substances List
  • 204427Orig1s000
  • Wo 2010/103544 A2
  • FEI Prohibited Substances List the 2011 List of FEI Prohibited Substances Will Come Into Effect on 4 April 2011
  • Customs Tariff - Schedule Xxi - 1
  • Parkinson's Disease in the United States
  • A Full Cycle Anti-Viral Drug Screen Identifies a Clinical Compound
  • Propietary Name Review(S)
  • Affinity Profiles of Hexahydro-Sila-Difenidol Analogues at Muscarinic Receptor Subtypes
  • 2019 Banned Substances List.Pdf
  • TAG Mail – 17 Dec 2020
  • Harmonized Tariff Schedule of the United States (2006) (Rev
  • ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
  • Euregio Laboratory Services MCP Aimed at Horses – Pharmacologic Drug Library
  • Figure S1. Rhod 2 Staining of Intracellular Calcium Depletion
  • (12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
  • (12) Patent Application Publication (10) Pub. No.: US 2009/0098207 A1 Malakhov Et Al


© 2024 Docslib.org    Feedback